Pig kidney transplants, known as xenotransplantation, are moving from laboratory research into human clinical trials. With approximately 90,000 people in the United States currently waiting for a kidney transplant and about 12 people dying every day while on the waiting list, this breakthrough represents a potential game-changer for kidney disease patients with no other treatment options .

How Do Scientists Make Pig Kidneys Compatible With Human Bodies?

The biggest challenge in transplanting a pig kidney into a human is the immune system, which naturally recognizes the organ as foreign and attacks it. To solve this problem, researchers use advanced gene-editing technology called CRISPR, often described as "magical scissors" that modify the pig's DNA .

Scientists make three key modifications to pig kidneys:

• Remove Rejection Triggers: Scientists delete pig genes that cause the human immune system to attack the organ.
• Add Human-Compatible Genes: Researchers insert human genes to make the kidney more compatible with the recipient's body.
• Reduce Infection Risk: Gene editing lowers the chance that infections could pass from pigs to humans.

Different research teams are testing pig kidneys with varying numbers of gene edits. United Therapeutics is studying a kidney with 10 gene edits called UKidney, while EGenesis is testing a more extensively modified kidney with 69 gene edits . These different approaches will help determine which genetic modifications work best for long-term kidney function in humans.

Have Pig Kidneys Actually Been Transplanted Into Living Patients Yet?

Yes, but the process has been carefully staged. Researchers first tested pig kidneys in animals, then performed experimental transplants in deceased donors to study how the organs function in the human body. In March 2024, scientists performed the first living kidney xenotransplant under "compassionate use," a special FDA pathway that allows experimental procedures for patients who are terminal with no other treatment options .

Based on findings from these early studies, the FDA approved clinical trials with living patients beginning in fall 2025. Multiple trials are now underway, testing different genetically engineered pig kidney products to determine which approach offers the best outcomes .

What Are the Common Misconceptions About Pig Kidney Transplants?

As with any new medical technology, several myths have emerged about xenotransplantation. One major concern is whether receiving a pig kidney would alter a patient's genetics. This is not the case.

"The pig kidney remains genetically different from the patient. It performs the job of filtering blood and maintaining balance in the body, but it does not integrate into the patient's DNA or alter their genetic makeup in any way," explained Dr. Riella, Medical Director of the Kidney Transplant Program at Massachusetts General Hospital.

Dr. Riella, Medical Director of Kidney Transplant Program at Massachusetts General Hospital

Another concern involves the risk of infections spreading from pigs to humans and potentially causing a pandemic. However, experts note that multiple safety layers are built into the process.

"There are multiple layers of safety built into the process, from screening and monitoring the donor animals to closely following patients after transplant. We use sensitive testing methods to detect any potential infections early. So far, the data we have is reassuring," stated Dr. Riella.

Dr. Riella, Medical Director of Kidney Transplant Program at Massachusetts General Hospital

A third misconception is that pig kidneys won't function the same as human kidneys. Researchers are actively studying this question, including whether the fact that pigs walk on four legs while humans stand upright affects kidney performance. Early evidence suggests pig kidneys can function similarly to human kidneys, though more long-term data is needed .

Who Will Be Eligible for Pig Kidney Transplants First?

Because xenotransplantation is still in early clinical trials, eligibility comes with specific limitations. Patients must live near a participating transplant center due to the intensive follow-up care and monitoring required after surgery. Additionally, participants will need a strong support system, including family members or loved ones who are willing to help with post-transplant care .

The first candidates will likely be patients who don't have a clear or quick path to receiving a traditional human kidney transplant. As the technology advances and more data accumulates, eligibility criteria may expand to include a broader patient population.

How to Prepare for the Future of Kidney Transplantation

If you or a loved one is waiting for a kidney transplant, here are important steps to take as xenotransplantation becomes available:

• Stay Informed: Learn about clinical trials in your area by checking with your transplant center or the National Kidney Foundation for updates on xenotransplant programs.
• Discuss Options With Your Doctor: Talk to your nephrologist about whether xenotransplantation might be appropriate for your situation and what the enrollment process involves.
• Build Your Support Network: Ensure you have family members or close friends who can commit to helping with post-transplant care and monitoring.
• Understand the Commitment: Be prepared for frequent follow-up appointments and close medical monitoring, as this is a new treatment requiring careful observation.

Experts emphasize that xenotransplantation is not a replacement for traditional kidney transplants or dialysis at this stage. Rather, it represents an additional option for patients who might otherwise have limited choices.

"The demand for kidneys far exceeds the number of available kidneys. Even with living donation and deceased donation, we're not able to meet the need. That's why exploring alternative sources of organs is so important," noted Dr. Riella.

Dr. Riella, Medical Director of Kidney Transplant Program at Massachusetts General Hospital

Researchers are hopeful that pig kidney xenotransplants could receive FDA approval for broader use within the next 5 to 10 years . As clinical trials continue and more data emerges about long-term outcomes, this technology could fundamentally change the landscape of kidney transplantation and offer hope to thousands of patients currently waiting for organs.